Skip to main content
. 2019 Apr 8;14:2515–2531. doi: 10.2147/IJN.S190502

Figure 4.

Figure 4

(A) NAT corneal permeation profile, (B) antifungal susceptibility testing, and (C) histopathological studies of optimized NAT-SLN formula.

Abbreviations: NAT, natamycin; NAT-SLN, NAT solid lipid nanoparticle.